Abstract
Monkeypox (MPOX) is a zoonotic viral disease caused by the Monkeypox virus (MPXV), which has become the most significant public health threat within the Orthopoxvirus genus since the eradication of the Variola virus (VARV). Despite the extensive attention MPXV has garnered, little is known about its clinical manifestations in humans. In this study, a high-throughput RNA sequencing (RNA-seq) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach was employed to investigate the transcriptional and metabolic responses of HEK293T cells to the MPXV A5L protein. RNA-seq analysis identified a total of 1473 differentially expressed genes (DEGs), comprising 911 upregulated and 562 downregulated genes. Additionally, LC-MS/MS analysis revealed 185 cellular proteins with significantly altered abundance ratios that interact with the A5L protein. Here, we perform Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of the transcriptome and proteome signatures of MPXV A5L-expressing HEK293T cells to gain insights into the virus proteins-host interplay. Transcriptomic analysis revealed that transfection of the MPXV A5L protein modulated genes primarily associated with the cell cycle, ribosome, and DNA replication. Proteomic analysis indicated that this protein predominantly interacted with host ribosomal proteins and cytoskeletal proteins. The combination of transcriptomic and proteomic analysis offers new perspectives for understanding the interaction between pathogens and hosts. Our research emphasizes the significant role of MPXV A5L in facilitating viral internalization and assembly, as well as its impact on the host’s translation system.
Keywords: transcriptome, proteome, monkeypox virus, A5L
1. Introduction
Monkeypox is a viral zoonotic infectious disease caused by the Monkeypox virus [1,2,3]. In 1958, MPXV was first identified during a vesicular disease outbreak in captive African monkeys that had been shipped to Copenhagen, Denmark, from Central and West Africa [4]. Sporadic cases of MPXV in humans were first identified in the 1970s in several African countries [3]. Subsequently, sporadic outbreaks of MPOX occurred in Africa, but these events received limited international attention. Between 2003 and 2022, there was an increase in the number of MPOX cases reported outside the epidemic countries, and the risk of human-to-human transmission of the virus remains a persistent threat [3]. The largest MPXV outbreak of the 21st century occurred in 2022, leading to epidemics in numerous countries [4]. The rapid spread of MPXV in 2022 led to the World Health Organization (WHO) declaring a Public Health Emergency of International Concern (PHEIC) [5]. As of 1 July 2024, more than 97,000 laboratory-confirmed human cases of MPOX had been reported (https://www.cdc.gov/mpox/data-research/cases/index.html, accessed on 1 July 2024).
MPXV is a large double-stranded DNA virus belonging to the Orthopoxvirus genus within the Poxviridae family, which also includes VARV, vaccinia virus (VACV), and Cowpox virus (CPXV) [1,3]. A distinctive feature used to distinguish VACV infections from MPXV infections is the swelling of the maxillary, cervical, or inguinal lymph nodes (lymphadenopathy) [3,5,6,7]. It contains a double-stranded DNA genome, which is approximately 197 kb in length and includes at least 190 open reading frames (ORFs) [5,8,9]. Phylogenetically, historic MPXV isolates cluster into two main clades, designated Clade I (Ia and Ib) and Clade II (II a and II b) [10,11,12]. Clade I viruses are considered more virulent and transmissible compared to Clade II viruses [13]. The viruses responsible for the 2022 epidemic belong to subclade IIb, a lineage that has been circulating in Nigeria since at least 1971 [3,10,14,15,16]. MPXV possesses a double-layered cell membrane and exhibits a brick-shaped morphology. It utilizes its double-stranded DNA genome to replicate within the host’s cytoplasm [17]. Although MPXV is a DNA virus, its entire lifecycle occurs in the cytoplasm of infected cells, where a variety of proteins essential for the replication machinery are encoded by ORFs within the MPXV genome [18]. Half of these ORFs are essential for viral replication and morphogenesis and are well conserved among other poxviruses [17,19]. The remaining half comprises “accessory” genes involved in immunomodulation, pathogenesis, and host tropism [17,19].
The A5L is 846 bp in length and encodes a 39 kD size A5L protein, which is a highly antigenic protein found in the viral core. Upton C et al.’s study reveals that MPXV A5L possesses gene or protein homologs (A4L) within the Chordopoxvirinae family, including A4L of Vaccinia virus (Copenhagen strain), A5L of the VACV WR strain (ATCC VR-119), and CPXV136 of Cowpox virus (Brighton strain) [20,21,22]. The research results on the MPXV A5L are limited. The protein is conserved in many Chordopoxvirinae subfamily (vaccinia viruses, horsepox virus, and cowpox virus, etc.), which means that the study of the A4L of Chordopoxvirinae subfamily could inform our study of MPXV A5L [21]. The VACV 39 kDa protein, the product of the A4L gene, is membrane associated and encapsidated into the virion [23]. A4L protein is phosphorylated in vivo and serves as a substrate for the F10L kinase in vitro. Its phosphorylation appears to be modulated by the expression of the viral H1 phosphatase [23]. Immunoelectron microscopy has revealed that antibodies against A4L protein decorate the interior of intracellular virion (IV) but not the nucleoid. Within mature virions (MV), these antibodies appear to localize to a region between the core and the membrane [23]. Pulse-chase and immunoprecipitation experiments have demonstrated that the 39 kDa protein interacts with p4a, which is encoded by the A10L gene and serves as the precursor to the most abundant virion protein [24]. This interaction is maintained with the processed 4a form that arises during virion maturation [24]. The colocalization of VACV WR A5L with replicated DNA in the virosomes and its copurification with nuclease activity has been reported [22]. This suggested a possible role for MPXV A5L during virus assembly.
In our research, to acquire transcriptomic information and identify interactions between MPXV-A5L protein and host proteins, HEK293T cells were transfected with either the pCAGGS-HA-A5L plasmid or the control pCAGGS-HA plasmid. Cells were harvested 24 h post-transfection and subjected to either RNA-seq or LC-MS/MS. GO and KEGG enrichment analyses were conducted to examine DEGs and potential host-interacting proteins identified in HEK293T cells overexpressing the A5L protein.
Our dataset highlights multiple signaling pathways and host proteins affected during MPXV A5L expression, thereby providing novel insights into understanding the pathogen-host interaction and aiding in the rational design of both virus- and host-directed therapies.
2. Results
2.1. Sequence Analysis of MPXV-A5L
To investigate the conservation of A5L among poxviruses, we conducted a phylogenetic analysis of MPXV-A5L (Figure 1A). We identified poxvirus proteins with amino acid sequences similar to MPXV-A5L, constructed a phylogenetic tree, and found that most of these proteins belong to Chordopoxvirinae (Figure 1A). Phylogenetic analysis revealed that MPXV-A5L and VACV-A5L exhibit shorter divergence times and closer evolutionary relationships compared to other poxvirus proteins (Figure 1A). When comparing the homology between MPXV-A5L (GeneBank: NC_063383.1) and VACV-A4L (GeneBank: AAA48120.1), we found that the two proteins share 95% sequence identity (Figure 1B).
Figure 1.
Amino acid sequence analysis of VACV-A4L and MPXV-A5L. (A) Molecular phylogenetic analysis of poxvirus A4L and MPXV A5L (highlighted in a red box). The tree with the highest log likelihood (−3224.27) is shown. The percentage of trees in which the associated taxa clustered together is indicated next to the branches. (B) Analysis of amino acid sequence identity between VACV-A4L (GeneBank: AAA48120.1) and MPXV-A5L (GeneBank: NC_063383.1). Red box with white characters indicates complete amino acid strict identity, white box with red characters indicates amino acid similarity, and black font on a white background indicates complete amino acid divergence.
2.2. Plasmid Construction and Immunoblot Analyses of MPXV A5L Protein
The pCAGGS-HA-A5L plasmid was constructed and verified by DNA agarose gel electrophoresis. The sequences “GAATTC” and “CTCGAG” at both ends of A5L represent EcoRⅠ and XhoⅠ cleavage sites, respectively (Figure 2A). Double digestion analysis confirmed the presence of two expected bands on the gel: one at approximately 5000 bp, representing the pCAGGS-HA vector, and another at 846 bp, representing the A5L gene (Figure 2B). Subsequently, the pCAGGS-HA-A5L plasmid was transfected into HEK293T cells, and the expression of the A5L protein was detected using an anti-HA antibody. Immunoblot results revealed three distinct 39 kDa bands corresponding to the A5L protein, confirming successful expression of the pCAGGS-HA-A5L plasmid in 293T cells (Figure 2C). Samples from immunoprecipitation (IP) and whole-cell lysate (WCL) after anti-HA incubation (Input) were subjected to immunoblot analyses, revealing a 39 kDa band corresponding to the A5L protein in pCAGGS-HA-A5L-transfected HEK293T cells (IP and Input) (Figure 2D). These results indicate that MPXV A5L protein was effectively captured by the anti-HA agarose conjugate.
Figure 2.
Construction and expression of MPXV A5L in HEK293T Cells. (A) Schematic representation of the cloned fragment. (B) Double digestion of the pCAGGS-HA-A5L plasmid. Lanes 1–5: The pCAGGS-HA-A5L recombinants were digested with EcoRI and XhoI. (C) Expression of MPXV A5L protein in HEK293T cells was followed by immunoblot analysis using anti-HA and anti-β-actin antibodies. M: 180 kDa protein molecular weight marker (8–180 kDa). Lanes 1–3: Cells transfected with pCAGGS-HA. Lanes 4–6: Cells transfected with pCAGGS-HA-A5L. (D) IP and whole-cell lysates (Input) used for immunoprecipitation were detected by immunoblotting with an anti-HA antibody. Lane 1: Cells transfected with pCAGGS-HA plasmid. Lane 2: Cells transfected with pCAGGS-HA-A5L plasmid.
2.3. Identification of DEGs
To assess the effects of the A5L protein on the transcriptome of HEK293T cells, we analyzed cellular transcriptome changes induced by A5L using HTSeq. Compared with HEK293T cells transfected with the pCAGGS-HA vector, a total of 1473 DEGs were identified in cells transfected with the pCAGGS-HA-A5L construct, including 911 upregulated and 562 downregulated genes (Figure 3A). Heatmap data revealed distinct differences in gene expression between the A5L group and the control group (Figure 3B). These findings indicate that A5L protein expression can significantly affect multiple genes and trigger substantial cellular responses.
Figure 3.
Identification of DEGs. (A) Volcano plot of DEGs. The vertical axis represents the significance (−log10 p-value), while the horizontal axis represents the log2 fold change in gene expression between the experimental and control groups. Downregulated genes by green dots, upregulated genes are indicated by red dots, and the threshold lines for DEGs screening criteria are shown as gray dashed lines. (B) Thermal polymerization map of DEGs. The left vertical axis represents the results of cluster analysis, while the horizontal axis denotes the sample names. The right vertical axis indicates gene names. The red color in the middle of the heatmap represents high expression, and the blue color represents low expression.
2.4. GO and KEGG Analysis of DEGs
GO analysis was performed to investigate the potential biological functions of the DEGs. The results indicated that the DEGs were categorized into three main groups: biological process (BP, 280 GO terms), cellular component (CC, 51 GO terms), and molecular function (MF, 20 GO terms). The top 30 enriched GO terms were presented in Figure 4A,B. BP including DNA replication (GO:0006260), protein targeting the membrane (GO:0006612) and ribosome biogenesis (GO:0042254) were highly enriched. In the CC category, the primary enriched terms included cytosolic ribosome (GO:0022626), ribosomal subunit (GO:0044391), and focal adhesion (GO:0005925). Within the MF category, A5L were predominantly associated with ATPase activity (GO:0016887), ribosomal structural components (GO:0003735), and catalytic activities targeting RNA (GO:0140098) (p < 0.01). These pathways also exhibited smaller adjusted p-values (padj) and a lower probability of false positives. The KEGG pathway enrichment analysis showed that the Cell cycle (hsa04110), Ribosome (hsa03010), and mTOR signaling pathway (hsa04150) were statistically significantly enriched (Figure 4C,D).
Figure 4.
Functional enrichment analysis of DEGs. (A) The scatter plot and (B) the histogram of GO analysis. (C) The scatter plot and (D) the histogram of KEGG analysis. The vertical axis represents the top 30 or 35 most significant terms, while the horizontal axis represents the gene ratio (A,C) or count (B,D). Gene ratio: The ratio of DEGs numbers to background gene numbers. Count: The number of DEGs. p-value: An indicator of term significance; smaller p-values indicate greater significance.
2.5. Varification of the RNA-Seq Data Through RT-qPCR
To validate the accuracy and reliability of the RNA-Seq data, RT-qPCR was employed to identify some DEGs. The real-time qPCR primers are shown in Table 1. We transfected pCAGGS-HA-A5L into HEK293T cells. Nine genes (HIF1A, CCL2, FAS, IGSF11, IFIH1, RAB3A, H2AC17, L1CAM, and AKT) were randomly selected for RT-qPCR analysis. The results showed that the expressions of HIF1A, CCL2, FAS, IGSF11, and IFIH1 were upregulated, while the expressions of RAB3A, H2AC17, L1CAM, and AKT were downregulated in pCAGGS-HA-A5L-transfected cells (Figure 5). The similarity of RT-qPCR data and RNA-Seq data indicated that the data from transcriptome was reliable.
Table 1.
The primer sets were used for real-time qPCR analysis.
| Gene | Sequence |
|---|---|
| (Human) HIF1α-F | TTTTGGCAGCAACGACACAG |
| (Human) HIF1α-R | GCGTTTCAGCGGTGGGTAAT |
| (Human) CCL2-F | TCAAACTGAAGCTCGCACTCT |
| (Human) CCL2-R | GGGGCATTGATTGCATCTGG |
| (Human) FAS-F | GTACGGAGTTGGGGAAGCTC |
| (Human) FAS-R | TTGATGTCAGTCACTTGGGCA |
| (Human) IGSF11-F | CTCTCTCTGCACGGTGTTGC |
| (Human) IGSF11-R | CATTGGAGAGAGGAGTGACCA |
| (Human) IFIH1-F | TCCATCGTTTGAGAACGCTCAT |
| (Human) IFIH1-R | CTGCAGCAGCAATCCGGT |
| (Human) RAB3A-F | AAAAGTCACCGCCGCTAGG |
| (Human) RAB3A-R | CTGCTGTTGCCGATGATGAG |
| (Human) H2AC17-F | TAGGCCACAGGTCGTTTTACC |
| (Human) H2AC17-R | CGTAGTTGCCCTTGCGGA |
| (Human) L1CAM-F | AGGTCCCTGGAGAGTGACAA |
| (Human) L1CAM-R | TACTGGCCAATGAACGAACCA |
| (Human) AKT-F | CCACACACTCACCGAGAACC |
| (Human) AKT-R | ACAGGTGGAAGAACAGCTCG |
| (Human) profilin1-F | ACGCCTACATCGACAACCTC |
| (Human) profilin1-R | CCTCAGCTGGCGTGATGT |
Figure 5.
RT-qPCR Validation of gene expression. We verified the expression levels of nine genes (HIF1A, CCL2, FAS, IGSF11, IFIH1, RAB3A, H2AC17, L1CAM, and AKT) using RT-qPCR in HEK293T cells after A5L protein expression. RNA expression levels were normalized to profilin1. Error bars represent the standard deviation (SD) from at least three independent experiments.
2.6. Interaction of MPXV A5L
The LC-MS/MS analysis was adopted to determine the interacting proteins of MPXV A5L protein for further study of its mechanism. Heterogeneous expression of MPXV A5L in HEK293T cells was immunoprecipitated using anti-HA beads, and the success of immunoprecipitation was confirmed by immunoblot (Figure 2D). The IP products were analyzed using LC-MS/MS, and the detailed results are summarized in Table 2. LC-MS/MS analysis identified a substantial number of ribosomal proteins (e.g., RPL8, RPL10A, and RPL7). The interaction between cytoskeleton proteins, including MYH9 and MYH10, with the MPXV A5L protein indicates that this protein may be involved in promoting the internalization of MPXV. Furthermore, our observations revealed a substantial presence of membrane proteins, including CALR, AMOT, and MYO6, suggesting that the MPXV A5L protein may play a critical role in regulating viral envelope formation and assembly. To further elucidate the biological functions and pathways of the identified proteins, we performed additional analysis using GO and KEGG enrichment methods. The GO analysis revealed that protein targeting to ER (GO:0045047) and translational initiation (GO:0006413) were prominent in BP, ribosome (GO:0005840) in the CC category, and actin binding (GO:0003779) and structural constituents of the ribosome (GO:0003735) were the most abundant GO terms in MF (Figure 6A,B). In the KEGG pathway enrichment analyses, the regulation of actin cytoskeletons (hsa04810), ribosomes (hsa03010), and spliceosomes (hsa03040) are significantly enriched (Figure 6C,D). The KEGG analysis revealed similar results between RNA-seq and mass spectrometry analysis, such as ribosome (hsa03010), RNA transport (hsa03013), and protein export (hsa03060) (Figure 4 and Figure 6).
Table 2.
The list of interacting protein.
| Accession | Score Sequest | Gene Symbol | Abundances (Control) | Abundances (A5L) | Fold |
|---|---|---|---|---|---|
| P55795 | 54.53 | HNRNPH2 | 23,845,270.8 | ||
| Q9NSB2 | 31.28 | KRT84 | 70,055,553.6 | ||
| P14649 | 21.06 | MYL6B | 53,201,279.2 | ||
| P62879 | 15.98 | GNB2 | 21,537,638.7 | ||
| P12814 | 10.43 | ACTN1 | 12,930,232 | ||
| Q9UHB6 | 7.13 | LIMA1 | 54,735,281.5 | ||
| Q15027 | 6.55 | ACAP1 | 78,746,156.2 | ||
| Q9BY77 | 5.8 | POLDIP3 | 24,037,837.6 | ||
| Q96EY4 | 5.36 | TMA16 | 17,209,636 | ||
| P35611 | 4.67 | ADD1 | 22,683,268.1 | ||
| P22695 | 4.57 | UQCRC2 | 7,952,299.99 | ||
| Q02241 | 4.16 | KIF23 | 17,128,696.1 | ||
| O00159 | 3.82 | MYO1C | 30,334,815.4 | ||
| P08758 | 2.96 | ANXA5L | 11,660,744.3 | ||
| P34897 | 2.82 | SHMT2 | 18,363,483.3 | ||
| O75251 | 2.74 | NDUFS7 | 15,064,159.9 | ||
| Q13523 | 2.72 | PRPF4B | 10,888,648 | ||
| Q9BXS6 | 2.67 | NUSAP1 | 18,715,571.1 | ||
| Q01650 | 2.62 | SLC7A5L | 16,038,306.4 | ||
| O15479 | 2.55 | MAGEB2 | 38,857,514.5 | ||
| Q9UBM7 | 2.55 | DHCR7 | 25,483,125.7 | ||
| Q13823 | 2.41 | GNL2 | 20,441,894.6 | ||
| O94973 | 2.32 | AP2A2 | 22,010,896.8 | ||
| P17028 | 2.32 | ZNF24 | 7,071,781.83 | ||
| Q52LG2 | 2.29 | KRTAP13-2 | 22,968,729.9 | ||
| P60953 | 2.2 | CDC42 | 12,173,080.3 | ||
| P08174 | 2.2 | CD55 | 47,053,652.5 | ||
| P27797 | 2.18 | CALR | 22,827,932.9 | ||
| Q9UHI6 | 2.13 | DDX20 | 7,576,214.22 | ||
| Q9NWT1 | 2.06 | PAK1IP1 | 11,007,573.8 | ||
| Q8WXE9 | 1.99 | STON2 | 24,510,051.4 | ||
| Q9BQG1 | 1.98 | SYT3 | 18,873,985.1 | ||
| P14210 | 1.94 | HGF | 19,177,626.6 | ||
| P49257 | 1.93 | LMAN1 | 24,788,012.4 | ||
| Q9UQ88 | 1.91 | CDK11A | 8,636,393.03 | ||
| Q15005 | 1.9 | SPCS2 | 5,468,154.27 | ||
| Q15323 | 1.88 | KRT31 | 60,750,663.2 | ||
| P62330 | 1.88 | ARF6 | 28,647,802.5 | ||
| P33992 | 1.87 | MCM5 | 7,625,153.14 | ||
| Q96S97 | 1.86 | MYADM | 20,177,422.3 | ||
| Q15046 | 1.86 | KARS1 | 9,191,269.95 | ||
| O00178 | 1.83 | GTPBP1 | 26,055,539.3 | ||
| Q9Y490 | 1.79 | TLN1 | 5,969,742.46 | ||
| Q96M91 | 1.77 | CFAP53 | 76,472,193.3 | ||
| Q15654 | 1.76 | TRIP6 | 17,252,038.1 | ||
| Q9P2M7 | 1.73 | CGN | 12,664,620.7 | ||
| O75915 | 1.68 | ARL6IP5 | 31,787,231.5 | ||
| Q93008 | 1.68 | USP9X | 7,286,550.55 | ||
| P35241 | 1.65 | RDX | 19,958,722.5 | ||
| Q9H307 | 1.63 | PNN | 6,374,994.83 | ||
| P48200 | 1.63 | IREB2 | 11,872,727.6 | ||
| Q96QK1 | 1.61 | VPS35 | 13,607,837.2 | ||
| Q96A26 | 1.61 | FAM162A | 19,597,430.9 | ||
| Q15056 | 1.61 | EIF4H | 6,669,397.13 | ||
| P35579 | 1106.8 | MYH9 | 7.6 × 109 | 3.8008 × 1010 | 4.997828 |
| P19338 | 393.64 | NCL | 4.32 × 109 | 2.1659 × 1010 | 5.010884 |
| P35580 | 718.97 | MYH10 | 2.3 × 109 | 1.0792 × 1010 | 4.686061 |
| Q4VCS5 | 320.95 | AMOT | 1.7 × 109 | 7,871,429,678 | 4.636524 |
| P62917 | 185.85 | RPL8 | 1.78 × 109 | 7,114,210,016 | 4.003225 |
| P62906 | 121.24 | RPL10A | 8.49 × 108 | 5,080,928,660 | 5.987087 |
| P18124 | 119.19 | RPL7 | 7.35 × 108 | 5,258,908,054 | 7.157648 |
| P62424 | 118.83 | RPL7A | 5.53 × 108 | 3,868,490,859 | 6.998979 |
| Q13813 | 109.9 | SPTAN1 | 3.8 × 108 | 1,852,745,858 | 4.874794 |
| P39023 | 105.74 | RPL3 | 4.8 × 108 | 4,126,009,236 | 8.593177 |
| P36578 | 104.96 | RPL4 | 5.6 × 108 | 3,130,805,766 | 5.590338 |
| Q8NC51 | 100.27 | SERBP1 | 5.29 × 108 | 2,247,852,488 | 4.252472 |
| P62241 | 85.38 | RPS8 | 9.77 × 108 | 6,094,990,507 | 6.237919 |
| P62266 | 84.37 | RPS23 | 3.6 × 108 | 1,797,616,211 | 4.998203 |
| Q07065 | 71.21 | CKAP4 | 1.68 × 108 | 794,929,264 | 4.719978 |
| P62753 | 70.84 | RPS6 | 5.11 × 108 | 2,638,295,624 | 5.158366 |
| Q07020 | 69.52 | RPL18 | 4.68 × 108 | 3,943,925,150 | 8.431103 |
| P61313 | 66.41 | RPL15 | 4.07 × 108 | 3,923,911,952 | 9.630158 |
| P26373 | 65.09 | RPL13 | 2.44 × 108 | 3,306,516,447 | 13.55998 |
| Q02878 | 63.03 | RPL6 | 3.75 × 108 | 1,579,582,645 | 4.213828 |
| P46777 | 62.53 | RPL5 | 3.06 × 108 | 1,550,140,466 | 5.058458 |
| P61353 | 62.24 | RPL27 | 3.83 × 108 | 3,286,606,950 | 8.57408 |
| P62888 | 55.07 | RPL30 | 3.32 × 108 | 1,832,429,225 | 5.517408 |
| Q9UNX3 | 52.15 | RPL26L1 | 4,933,386 | 23,405,671.6 | 4.744343 |
| P27635 | 51.33 | RPL10 | 2.26 × 108 | 943,176,519 | 4.177723 |
| Q02543 | 51.22 | RPL18A | 4.56 × 108 | 2,303,106,278 | 5.051142 |
| Q9Y3U8 | 49.59 | RPL36 | 5.96 × 108 | 3,349,708,990 | 5.618173 |
| P62854 | 45.66 | RPS26 | 1.99 × 108 | 1,494,638,724 | 7.527102 |
| Q9UM54 | 45.24 | MYO6 | 63,204,009 | 734,670,570 | 11.6238 |
| Q92522 | 44.99 | H1-10 | 1.63 × 108 | 678,302,362 | 4.173634 |
| P46776 | 43.04 | RPL27A | 3.6 × 108 | 1,757,091,613 | 4.884333 |
| Q01082 | 42.52 | SPTBN1 | 70771524 | 566,802,222 | 8.008902 |
| P62910 | 41.13 | RPL32 | 2.87 × 108 | 1,269,884,943 | 4.431853 |
| P53621 | 41.12 | COPA | 1.46 × 108 | 724,068,452 | 4.953142 |
| P46087 | 36.96 | NOP2 | 1.07 × 108 | 1,173,149,722 | 10.98216 |
| Q08170 | 32.18 | SRSF4 | 2.52 × 108 | 1,535,299,732 | 6.084086 |
| Q16643 | 30.41 | DBN1 | 31,211,853 | 767,446,859 | 24.58831 |
| P61513 | 28.38 | RPL37A | 2.3 × 108 | 1,238,388,622 | 5.394924 |
| P31946 | 27.98 | YWHAB | 7,652,528 | 77,359,209.5 | 10.10898 |
| O94832 | 25.9 | MYO1D | 2,752,137 | 357,771,870 | 129.9978 |
| Q9NQ29 | 25.17 | LUC7L | 5,746,320 | 23,316,664.9 | 4.057669 |
| O43795 | 25.12 | MYO1B | 47,966,804 | 449,804,703 | 9.377417 |
| P12277 | 23.32 | CKB | 79,100,780 | 350,631,774 | 4.432722 |
| E9PAV3 | 22.7 | NACA | 54,653,562 | 494,198,804 | 9.04239 |
| P46779 | 21.98 | RPL28 | 97,888,915 | 544,056,692 | 5.557899 |
| Q8N3R9 | 19.26 | PALS1 | 20,378,481 | 154,737,012 | 7.593157 |
| P08754 | 19.24 | GNAI3 | 60,146,303 | 479,782,974 | 7.976932 |
| P50914 | 19.15 | RPL14 | 1.78 × 108 | 1,393,870,977 | 7.83708 |
| P40429 | 19.01 | RPL13A | 1.89 × 108 | 1,509,570,649 | 7.967573 |
| P49207 | 18.93 | RPL34 | 3.87 × 108 | 2,066,637,763 | 5.346116 |
| Q9UMS4 | 17.92 | PRPF19 | 1.35 × 108 | 661,151,564 | 4.913278 |
| P42766 | 16.42 | RPL35 | 1.73 × 108 | 828,704,701 | 4.791414 |
| O95793 | 16.04 | STAU1 | 34,599,041 | 146,473,177 | 4.233446 |
| Q9P2E9 | 15.7 | RRBP1 | 36,221,922 | 171,298,674 | 4.729144 |
| Q15149 | 14.76 | PLEC | 13,070,259 | 222,413,318 | 17.01675 |
| Q9H7B2 | 14.29 | RPF2 | 12565969 | 145,092,561 | 11.54647 |
| P61006 | 14.02 | RAB8A | 2,400,302 | 16,719,589.6 | 6.965618 |
| Q13610 | 13.96 | PWP1 | 18,865,848 | 141,208,069 | 7.484852 |
| P62633 | 13.76 | CNBP | 23,925,131 | 176,695,010 | 7.385331 |
| O43707 | 13.27 | ACTN4 | 24,205,268 | 136,102,708 | 5.622855 |
| P47914 | 13.01 | RPL29 | 5.9 × 108 | 2,512,280,276 | 4.256594 |
| P13987 | 12.93 | CD59 | 33,261,676 | 215,455,509 | 6.47759 |
| Q8TDN6 | 12.65 | BRIX1 | 10,376,578 | 168,688,087 | 16.25662 |
| Q04637 | 10.76 | EIF4G1 | 29,253,382 | 146,869,232 | 5.02059 |
| P08621 | 9.91 | SNRNP70 | 23,918,842 | 160,794,203 | 6.722491 |
| Q9BZE4 | 9.69 | GTPBP4 | 30,334,456 | 218,282,534 | 7.195861 |
| Q9Y678 | 9.66 | COPG1 | 14,504,055 | 58,685,143.1 | 4.04612 |
| Q8NE71 | 9.47 | ABCF1 | 9,205,467 | 48,876,803.4 | 5.309541 |
| Q07157 | 9.45 | TJP1 | 9,895,750 | 53,372,921.9 | 5.39352 |
| Q9BQG0 | 8.69 | MYBBP1A | 26,923,852 | 147,077,400 | 5.462718 |
| O43242 | 8.51 | PSMD3 | 24,866,727 | 121,259,423 | 4.876372 |
| P49756 | 8.1 | RBM25 | 12,400,093 | 88,151,215.8 | 7.108916 |
| O75400 | 7.98 | PRPF40A | 27,402,617 | 116,759,966 | 4.260906 |
| Q14684 | 7.93 | RRP1B | 69,654,704 | 353,008,391 | 5.067976 |
| P08243 | 7.75 | ASNS | 16,356,520 | 223,274,864 | 13.65051 |
| Q9Y2X3 | 7.6 | NOP58 | 3,452,465 | 59,794,539.1 | 17.31938 |
| P05455 | 7.34 | SSB | 13,230,934 | 94,151,395.8 | 7.116005 |
| Q01105 | 7.24 | SET | 32,879,772 | 135,036,667 | 4.106983 |
| Q9NW13 | 7 | RBM28 | 8,323,326 | 100,335,155 | 12.05469 |
| P42696 | 6.65 | RBM34 | 8,732,097 | 40,401,561.4 | 4.626788 |
| Q5JWF2 | 6.47 | GNAS | 4,735,516 | 74,347,665.1 | 15.70001 |
| Q8IY81 | 6.47 | FTSJ3 | 3,963,930 | 44,935,915.6 | 11.3362 |
| Q9NX58 | 6.36 | LYAR | 11718590 | 65,237,865.7 | 5.567041 |
| P63000 | 5.98 | RAC1 | 18,650,276 | 99,502,685.4 | 5.335186 |
| P61221 | 5.79 | ABCE1 | 15,830,286 | 150,435,816 | 9.503039 |
| P62891 | 5.71 | RPL39 | 29,916,276 | 163,424,396 | 5.462725 |
| Q96CW1 | 5.68 | AP2M1 | 13,251,519 | 61,822,112 | 4.665285 |
| P40939 | 5.47 | HADHA | 13,623,453 | 67,584,883.9 | 4.960922 |
| Q9BRJ6 | 5.46 | C7orf50 | 19,859,188 | 95,007,628.2 | 4.784064 |
| Q9H9B4 | 5.06 | SFXN1 | 9,005,179 | 216,387,269 | 24.0292 |
| Q86VP6 | 5.04 | CAND1 | 8,920,870 | 66,555,261.6 | 7.460625 |
| Q6P2Q9 | 5.03 | PRPF8 | 2,161,177 | 38,374,317.9 | 17.75621 |
| P46940 | 4.91 | IQGAP1 | 7,938,699 | 109,080,082 | 13.7403 |
| Q9Y295 | 4.81 | DRG1 | 4747110 | 19,024,856.7 | 4.007671 |
| Q13642 | 4.8 | FHL1 | 2,702,271 | 45,495,752.3 | 16.83612 |
| Q9BUJ2 | 4.76 | HNRNPUL1 | 9,271,129 | 58,503,614.9 | 6.310301 |
| O14654 | 4.56 | IRS4 | 6,215,177 | 50,639,493.4 | 8.147716 |
| O60763 | 4.52 | USO1 | 4,183,194 | 24,127,383.2 | 5.767694 |
| O75643 | 4.44 | SNRNP200 | 9,569,121 | 70,538,432.2 | 7.371464 |
| O43592 | 4.27 | XPOT | 5,525,361 | 30,283,421.8 | 5.480805 |
| Q86UP2 | 4.24 | KTN1 | 12,269,741 | 77,750,053.4 | 6.336731 |
| Q9P2J5 | 4.2 | LARS1 | 18,835,668 | 82,710,799.8 | 4.39118 |
| Q86VM9 | 3.96 | ZC3H18 | 2,471,121 | 24,366,387.4 | 9.860458 |
| O76094 | 3.95 | SRP72 | 9,620,050 | 41,076,561.6 | 4.269891 |
| Q9UKD2 | 3.95 | MRTO4 | 7,057,619 | 78,872,065.8 | 11.17545 |
| Q14697 | 3.56 | GANAB | 9,795,123 | 61,834,988.6 | 6.312834 |
| P53396 | 3.37 | ACLY | 6,139,189 | 28,311,705.6 | 4.611636 |
| Q01780 | 2.86 | EXOSC10 | 3,204,284 | 16,656,062.6 | 5.198061 |
| Q86UE4 | 2.71 | MTDH | 8,321,409 | 35,187,694.4 | 4.228574 |
| P63151 | 2.62 | PPP2R2A | 5,711,416 | 36,989,877.6 | 6.476481 |
| Q9NZM5 | 2.61 | NOP53 | 5,430,802 | 30,995,616 | 5.707374 |
| O75369 | 2.57 | FLNB | 2,276,534 | 61,851,286.7 | 27.16906 |
| Q8NI35 | 2.39 | PATJ | 3,567,723 | 48,585,809.7 | 13.61816 |
| Q03701 | 2.18 | CEBPZ | 4,374,025 | 17,743,194.8 | 4.056491 |
| Q92896 | 2.18 | GLG1 | 800,199.9 | 4,717,955.06 | 5.89597 |
| Q9Y4P3 | 2.17 | TBL2 | 5,922,978 | 43,983,036.8 | 7.425832 |
| Q16630 | 2.16 | CPSF6 | 11,481,576 | 50,123,009.6 | 4.365517 |
| Q9H4G4 | 2.15 | GLIPR2 | 5,717,304 | 30,078,632.4 | 5.260982 |
| O95831 | 2.13 | AIFM1 | 3,878,012 | 45,361,458.8 | 11.69709 |
| P20290 | 2.08 | BTF3 | 6,736,184 | 28,957,538.5 | 4.298805 |
| Q92558 | 2.01 | WASF1 | 1,504,043 | 7,875,298.01 | 5.236086 |
| P13010 | 1.96 | XRCC5 | 1,067,594 | 24,486,127.9 | 22.93581 |
| Q8NB91 | 1.91 | FANCB | 4.13 × 109 | 1.7678 × 1010 | 4.283121 |
| Q9H0A0 | 1.9 | NAT10 | 5,435,425 | 42,088,224.7 | 7.743318 |
| P78347 | 1.9 | GTF2I | 4,062,462 | 57,972,505.3 | 14.27029 |
| P06493 | 1.83 | CDK1 | 9,830,338 | 97,019,514.9 | 9.869398 |
| O00231 | 1.76 | PSMD11 | 6,285,229 | 36,586,283.9 | 5.820995 |
| Q8TEX9 | 1.74 | IPO4 | 3,142,446 | 18,886,047 | 6.009983 |
| Q14839 | 1.73 | CHD4 | 5,117,228 | 22,926,902 | 4.480337 |
| Q5T8P6 | 1.63 | RBM26 | 3,233,657 | 14,625,610.8 | 4.522932 |
Figure 6.
Functional enrichment analysis of proteins interacting with A5L. (A) The scatter plot and (B) the histogram of GO analysis. (C) The scatter plot and (D) the histogram of KEGG analysis. The horizontal axis indicates the gene ratio (A,C) or count (B,D). The vertical axis shows the top 30 or 25 most significance terms. Gene ratio: the ratio of the interacting proteins number to background proteins number. Count: the number of the interacting proteins. p-value: indicators of the significance of the term, the smaller the p-value.
3. Discussion
Over the past two years, MPXV has emerged as a zoonotic disease with significant implications for global public health [25,26]. Recently, the WHO Director-General declared the mpox outbreak a Public Health Emergency of international concern on 14 August 2024. Current case data indicate that MPXV outbreaks are becoming increasingly frequent, highlighting the ongoing risk posed by the genomic dynamics of DNA viruses for transmission and evolution within vulnerable populations [26,27]. With over 100,000 reported infections worldwide and no specific treatments available, there is an urgent need to investigate the gene functions and pathogenic mechanisms of MPXV [26,27]. MPOX poses a significant threat to global public health and security. Unfortunately, the underlying infection mechanisms of MPXV remain poorly understood. The research results on the MPXV core protein are limited. The core protein demonstrates notable conservation in poxviruses and shows potential as a novel avenue to target to develop pan-poxvirus vaccines or antiviral strategies. The membrane-free core of poxvirus consists of at least five abundant proteins, namely gene products of A3L, A4L, A10L, L4R, and F17R [28]. Except for F17R, these proteins are also associated with the incoming cytoplasmic core during the early stages of infection [28].
Given the aforementioned reasons, we investigated the characteristics and functions of the MPXV A5L protein using RNA-seq and LC-MS/MS. In this study, a total of 1473 DEGs were identified, including 911 upregulated and 562 downregulated genes, as well as 185 cellular proteins that interact with the MPXV A5L protein.
Viruses are obligate intracellular parasites that must rely on host cells to fulfill their genome replication requirements [29]. Viruses have evolved various mechanisms to redirect the host’s ribosomes toward their viral mRNAs [18]. As the virus hijacks the host translation machinery, the diversity of translating mRNAs decreases dramatically from tens of thousands of host mRNA species to only a few hundred viral mRNAs [30]. Similarly to all viruses, in order to ensure the efficient translation of virus proteins, VACV inhibits host protein synthesis and redirects the cellular translational machinery to the synthesis of viral proteins [31]; Newcastle disease virus (NDV) manipulates host translation mechanisms to facilitate viral replication [32]. A near-complete shutdown of host protein translation is induced by severe acute respiratory syndrome coronavirus (SARS-CoV) Nsp1 through a two-pronged strategy [33]. LC-MS/MS analysis revealed a significant quantity of ribosomal proteins interacting with MPXV A5L protein. These genes are associated with various GO terms related to ribosomal subunits, including cytosolic large ribosomal subunit (GO:0022625), cytosolic ribosome (GO:0022626), large ribosomal subunit (GO:0015934), and ribosome (GO:0005840). Some of the genes involved are RPL8, RPL10A, RPL7, RPL7A, RPL3, RPL4, RPS8, RPS23, RPL18, RPL15, RPL13, RPL5, and RPL6. RNA-seq analysis revealed that these differentially expressed genes (DEGs) are primarily associated with translation-related pathways such as the Ribosome pathway and the mTOR signaling pathway. In two additional mass spectrometry studies on MPXV proteins, the A23R protein was found to interact with various ribosomal proteins, whereas the F3L protein did not [5,26]. Both the A23R protein and A5L protein interact with a large number of ribosomal proteins but differ in their specific interactions. Specifically, A23R protein can bind to unique ribosomal proteins, including RPS15A, RPL17, and RPS16. The F3L protein interacts with host proteins involved in RNA splicing and protein translation, such as SNRNP70 and HNRNPH1 [5,26]. Similarly, the A5L protein also interacts with these host proteins, including SNRNP70 and HNRNPH2. KEGG pathway enrichment analyses revealed that the three MPXV proteins (A5L, A23R, and F3L) are involved in the spliceosome pathway and translation-related pathways. The observation suggested that the A5L protein has the ability to manipulate ribosomes in order to inhibit the host’s immune response and aid in viral transcription.
Poxviruses demonstrate an extraordinary degree of self-sufficiency and complexity in their replication and immune evasion strategies [18]. However, like all other viruses, poxviruses do not encode ribosomes and therefore remain entirely dependent on accessing the host translational machinery to synthesize viral proteins [34]. MPXV and other viruses impact host cell metabolism by dysregulating mTOR and the translation machinery (e.g., RACK1) to divert host resources toward the biosynthesis of viral components [18,25,35,36]. RACK1, which is part of the ribosome machinery, is phosphorylated by VACV to increase translation [25]. Alexis et al. showed that RACK1 is associated with RNA-binding proteins SERBP1 to facilitate Dengue virus (DENV) replication [37]. Avian leukosis virus (ALV) usurps the cellular SERBP1 protein to enhance its transcription and promote productive infections [38]. VACV kinase B1 phosphorylates the host small ribosomal protein RACK1, which enhances ribosome recruitment to poly(A) leader mRNAs [18,30,39]. SERBP1 is a member of the RG/RGG family of RNA-binding proteins, which regulates mRNA translation, but known protein patterns suggest additional regulatory functions [40,41,42,43]. The process of uncoating, whereby the proteinaceous core wall is breached and the DNA is released into the cytoplasm, is a crucial event in the temporal regulation of the viral genome cycle [44]. Once uncoating occurs and the viral core disassociates, early gene transcription ceases, presumably as a result of the dilution of the transcriptional machinery into the cytoplasm [44]. Our mass spectrometry data show that the SERBP1 and some ribosomal proteins interact with the MPXV A5L protein. This suggests that the MPXV A5L protein may enhance translation of viral proteins by affecting ribosomal function, warranting further investigation and confirmation.
The assembly of poxviruses starts with viral crescent [45]. This viral crescent grows until it forms a spherical structure called the immature virion. Maturation of these particles produces a brick-shaped virion, the mature virion [45]. Depending on the poxvirus genus, MVs may be enclosed by an additional membrane derived from the trans-Golgi, endosomal cisternae or plasma membrane to form wrapped virions (WVs) and transported to the cell periphery and exocytosed as extracellular enveloped virions (EEVs) [46]. Monkeypox is a member of the poxvirus and exists in two distinct infectious forms, the IMV and the EEV [3]. Mature virions possess three distinct layers: an outer envelope, an intermediate capsid-like layer, and an inner core [45]. The wrapping of IMVs by intracellular membranes requires the interaction between virus protein(s) on the IMV surface and the cytosolic face of the wrapping membranes [47]. The MPXV A5L protein is a homologue of the VACV A4L protein (Figure 1B). VACV A4L protein is most likely membrane associated through an interaction with an integral membrane protein(s) present in the innermost of the two membranes surrounding the IMV [48]. Indeed, in mature virions, the A4L protein binds to the outer domain of A10L, potentially tethering the palisade layer to the viral membrane [45]. This tethering could be necessary if confirmed, as it may explain how, during maturation, the spherical membrane previously stabilized by the immature virion scaffold collapses onto the core as it condenses [45]. Thus, A4L appears to be necessary for core assembly during the IV to MV transition [23]. According to LC-MS/MS analysis, MPXV A5L protein interacts with a variety of membrane proteins, such as SPTAN1, SPTBN1, CALR, and MYO6. Collectively, our findings highlight the potential role of MPXV A5L protein in virus assembly.
The replication process of poxviruses is distinctive and comprises several stages, beginning with attachment to host cells and culminating in the release of viral particles from infected cells [49]. MPXV, similar to other poxviruses, significantly disrupts cellular homeostasis by hijacking cytoskeleton organization to facilitate intracellular virion transport [25]. We observed the enrichments of DEGs in cytoskeleton-related pathways, such as myosin complex (GO:0016459), actin filament (GO:0005884), cell cortex (GO:0005938) and actin filament bundle (GO:0032432), etc. Additionally, interactions were also observed between the A5L protein and cytoskeletal proteins, including MYH9, MYH10, AMOT, etc. MYH9, also known as non-muscle myosin heavy chain 9, was first identified as a motor protein involved in cell migration, adhesion, and morphogenesis [50]. Complete virion internalization involves interactions between viral proteins and cellular receptors, as well as clathrin-mediated endocytosis facilitated by MYH9, an essential factor [50]. Studies have demonstrated that herpes simplex virus-1 (HSV-1), thrombocytopenia syndrome virus (SFTSV), Epstein–Barr virus (EBV), and Porcine reproductive and respiratory syndrome virus (PRRSV) rely on MYH9 as a crucial factor for infecting permissive cells [50,51,52]. Additionally, AMOT plays a significant role as a key regulator in various physiologically relevant pathways and processes, including transcription (via the Hippo pathway), apoptosis, cytoskeleton dynamics, and tight junction (TJ) integrity [53]. In the absence of AMOT, most virions were arrested at a ’half-moon’ stage, characterized by a hemisphere of assembled Gag molecules distending the membrane without forming a complete spherical particle [54]. These results suggested that MPXV A5L protein might have the ability to hijack cytoskeleton organization to facilitate virus internalization and assembly.
Currently, there is limited research available on the pathogenesis and life cycle of the MPXV. The primary focus of current research efforts is on developing vaccines, antiviral drugs, and accurate diagnostic methods for MPOX. Our findings highlight the potential role of MPXV A5L protein in regulating host gene expression and facilitating virus internalization and assembly. In the future, these findings need to be validated using techniques such as pull-down assays and fluorescence resonance energy transfer (FRET).
4. Conclusions
The global spread of MPXV has underscored the need for a deeper understanding of MPOX disease, particularly in comparison to other poxviruses. Transcriptomic and proteomic analyses of viruses have significantly advanced our knowledge of epidemic and pandemic viruses, facilitating drug development. The findings highlight the crucial role of the monkeypox virus A5L protein in the viral lifecycle. In addition to its involvement in viral morphogenesis, this protein may also play roles in (1) promoting viral internalization and assembly and (2) modulating the host translation system.
5. Materials and Methods
5.1. Cell Culture
HEK293T cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Solarbio, Beijing, China) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (ExCell Bio, Shanghai, China) at 37 °C in a humidified atmosphere containing 5% CO2. The HEK293T cells were obtained from the China Type Culture Collection.
5.2. Plasmids Construction Transfection
The p39 protein-encoding gene A5L was synthesized according to the sequence of the MPXV strain MPXV-USA_2022_MA001 (GenBank No. NC_063383.1) and the gene synthesized by Beijing Tsingke Biotech Co., Ltd., Beijing, China. Primers were designed according to the MPXV-A5L gene sequence. The MPXV-A5L gene was inserted into the EcoR I and Xho I sites of the pCAGGS-HA plasmid to generate the pCAGGS-HA-A5L construct. MPXV A5L coding sequence was amplified via PCR using the forward primer 5′-CCGGAATTCATGGATTTTTTTAACAAATTTAGTCAGGG-3′ (EcoR I site underlined) and the reverse primer 5′-CCGCTCGAGTTTCTGAAAACGTTCAAAAC-3′ (Xho I site underlined). The resulting clones were verified by DNA sequencing. Plasmid transfection was performed using jetPRIMER® Transfection Reagent (PolyPlus, Illkirch-Graffenstaden, France) following the manufacturer’s instructions.
5.3. DNA Transfection
293T cells were seeded in 6-well plates at a density of 2.5 × 105 cells per well or in 10 cm dishes at a density of 1 × 106 cells per well the day before transfection. pCAGGS-HA-A5L plasmid was transfected into the designated cells accordingly. 24 h post-transfection, a portion of the transfected cells was lysed in Trizol (Vazyme, Nanjing, China) for RNA extraction and subsequent RT-qPCR. The remaining cells were lysed in RIPA buffer (Solarbio, Beijing, China) for further Immunoblot analyses and immunoprecipitation. Cells transfected with an empty vector (pCAGGS-HA) served as a negative control.
5.4. RNA-Seq and Data Processing
RNA-seq were performed as described previously [5]. RNA-seq was performed to compare gene expression profiles between pCAGGS-HA-A5L-transfected 293T cells and pCAGGS-HA (empty vector)-transfected 293T cells over a 24 h time period. Three randomly selected samples from each group were used to prepare RNA-seq libraries. Total RNA was extracted from each individual sample using Trizol reagent (Invitrogen, Waltham, MA, USA). The quality and quantity of the total RNA were assessed using a NanoDrop spectrophotometer and an Agilent 2100 Bioanalyzer (Thermo Fisher Scientific, Waltham, MA, USA). Subsequently, mRNA was isolated using poly-T oligo-attached magnetic beads and then fragmented in fragmentation buffer at an appropriate temperature. First-strand cDNA was synthesized using random hexamers, followed by second-strand cDNA synthesis. End repair was performed by adding A-Tailing Mix and RNA Index Adapters. The cDNA fragments were PCR amplified and purified using Ampure XP beads. The products were validated on an Agilent 2100 Bioanalyzer (Thermo Fisher Scientific, USA) for quality control. The cDNA libraries were generated using the NEBNext® Ultra™ RNA Library Prep Kit for Illumina® (NEB, Ipswich, MA, USA) and sequenced on the Illumina NovaSeq 6000 platform (Illumina, San Diego, CA, USA).
The RNA-seq analysis was conducted by Novogene Biotech. Raw sequences were quality-controlled and filtered using fastp software (v0.23.1). To obtain high-quality data for downstream analyses, raw reads were was filtered using SOAPnuke (v1.5.2) to remove primer sequences and low-quality reads. Q20, Q30 and GC content of the clean reads were calculated in this process. The clean reads were mapped onto the Homo sapiens reference genome (GRCh38) using Hisat2 (v2.0.4) software with default parameters. Bowtie2 (v2.2.5) was applied to align the clean reads to the reference genome and StringTie (v2.1.2) was used to calculate fragments per Kilobase of transcript per million fragments mapped (FPKM) values for each gene. The differential expression analysis was performed using the DESeq2 (v1.4.5) with a significance criterion of Padj ≤ 0.05 and |log2(FC)| ≥ 0.35. The functional enrichment of DEGs were analyzed by Phyper (https://en.wikipedia.org/wiki/Hypergeometric_distribution, accessed on 25 September 2024) to identify enriched GO terms and KEGG pathways with a screening criterion of p < 0.05. Heatmaps were generated using an online platform for data analysis and visualization (https://www.bioinformatics.com.cn, accessed on 29 September 2024).
5.5. Real-Time Quantitative PCR (RT-qPCR)
To validate the reliability of the RNA-Seq data, 9 DEGs (HIF1A, CCL2, FAS, IGSF11, IFIH1, RAB3A, H2AC17, L1CAM, and AKT) were arbitrarily selected for RT-qPCR analysis. Total RNA was extracted from these splenocytes with TRIzol reagent following the supplier’s instructions. cDNA synthesis was performed according to the manufacturer’s protocols. RT-qPCR was developed in a QuantStudio 5 Real-Time PCR system (Applied Biosystems, Waltham, MA, USA). Each RT-qPCR was conducted in triplicate in 20 μL of total reaction volume, containing 10 μL of Universal SYBR Green Master mix, 1 μL of cDNA, and a pair of gene-specific primers. The RT-qPCR conditions were as follows: a pre-incubation (95 °C, 30 s), 40 amplification cycles (95 °C, 10 s; 60 °C, 30 s), and a final extension (95 °C, 15 s; 60 °C, 60 s). The expression levels of transcripts were normalized to that of the β-actin gene. The fold change in the expression of each target gene was estimated using the 2−ΔΔCt method. The real-time qPCR primers are shown in Table 1.
5.6. Immunoblots Analyses
Immunoblots were performed as described previously [26]. Briefly, the cells were washed with PBS and lysed with RIPA Lysis Buffer. The lysates and protein samples were mixed with SDS sample loading buffer, boiled for 10 min, separated by SDS-PAGE, and transferred to polyvinylidene fluoride membranes (Millipore, Burlington, MA, USA). After blocking, the membranes were probed with the primary antibodies, followed by incubation with horseradish peroxidase-conjugated secondary antibody. The target proteins were visualized by using MonPro ECL Ultrasensitive Substrate Pro (Monad, Wuhan, China).
5.7. LC-MS/MS and Data Processing
LC-MS/MS were performed as described previously [26]. Briefly, HEK293T cells transfected with the pCAGGS-HA-A5L vector or the control vector were lysed in RIPA buffer (Solarbio, Beijing, China) supplemented with protease and phosphatase inhibitors. Cell lysates were incubated with anti-HA-agarose beads (Sigma Aldrich, Darmstadt, Germany) at 4 °C overnight. The beads were subsequently collected by centrifugation and washed with PBS before LC-MS/MS analysis. LC-MS/MS experiments and data analysis were conducted by Oebiotech. In brief, the proteins bound to the beads were denatured with 8 M urea in 50 mM NH4HCO3. The protein samples were sequentially reduced with dithiothreitol (DTT) (final concentration, 10 mM) at 55°C for 30 min, alkylated with iodoacetamide (final concentration, 15 mM), enzymatically hydrolyzed with trypsin overnight, and desalted with C18 columns. Peptides were analyzed on a Q Exactive-HF mass spectrometer (Thermo Scientific, USA) coupled with an Easy-nLC 1200 (Thermo Scientific, USA). The MS/MS signals were then processed against the National Center for Biotechnology Information (NCBI, Bethesda, MD, USA) protein database by using the Mascot Server (Matrix Science, Boston, MA, USA). Proteins with a ratio of abundance (A5L group/Control group) > 4 and score > 0 are considered to interact with A5L proteins. High-confidence peptides were selected and listed in Table 2. The protein “score” represents the standard score, which is the cumulative protein score obtained by summing the ion scores of the unique peptides. A higher score signifies greater confidence in identification. The pathway analysis was conducted using KOBAS (https://bioinfo.org/kobas/, accessed on 28 September 2024). The GO and KEGG pathways of p values less than 0.05 were considered significant and highly significant.
5.8. Statistical Analysis
Data were analyzed using GraphPad Prism 9.0 software to determine statistical significance. Inter-group statistical differences were assessed using Student’s t-test. p < 0.05 was considered statistically significant.
Abbreviations
| MPOX | Monkeypox |
| MPXV | Monkeypox virus |
| VARV | Variola virus |
| CPXV | Cowpox virus |
| VACV | Vaccinia virus |
| RNA-seq | RNA sequencing |
| LC-MS/MS | Liquid chromatography-tandem mass spectrometry |
| HEK293T Cell | Human Embryonic Kidney 293 Cells |
| GO | Gene Ontology |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| WHO | World Health Organization |
| PHEIC | Public Health Emergency of International Concern |
| ORFs | open reading frames |
| IMV | Intracellular mature virion |
| IV | Intracellular virions |
| MV | Mature virions |
| DEGs | differentially expressed genes |
| Co-IP | Co-immunoprecipitation |
| WCL | Whole-cell lysate |
| BP | biological process |
| CC | cellular component |
| MF | molecular function |
| NDV | Newcastle disease virus |
| SARS-CoV | Severe acute respiratory syndrome coronavirus |
| DENV | Dengue virus |
| ALV | Avian leukosis virus |
| WV | Wrapped virions |
| EEV | Extracellular enveloped virion |
| HSV-1 | Human simplex virus-1 |
| SFTSV | Thrombocytopenia syndrome virus |
| EBV | Epstein–Barr virus |
| PRRSV | Porcine reproductive and respiratory syndrome virus |
| FPKM | fragments per kilobase of transcript per million mapped reads |
| DTT | dithiothreitol |
| NCBI | National Center for Biotechnology Information |
Author Contributions
M.L.: Writing—review and editing; validation; formal analysis; investigation; writing—original draft; J.X.: writing—review and editing; validation; formal analysis; investigation; H.Z.: validation; J.L.: validation; C.W.: formal analysis; M.J.: investigation; Y.W.: formal analysis; N.Z.: validation; Y.C.: validation; T.Z.: validation; Z.Z.: formal analysis; R.L.: validation; Y.Z.: validation; Y.G.: writing—review and editing; Q.P.: writing—review and editing, conceptualization, methodology; L.K.: conceptualization, methodology, writing—review and editing, supervision project, administration, funding acquisition. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.
Informed Consent Statement
The institute of Pathogenic Microorganism at Jiangxi Agricultural University in Nanchang, Jiangxi, China, approved the publication of data generated from this study.
Data Availability Statement
The original contributions presented in the study are publicly available. This RNA-seq data can be found here: [NCBI/PRJNA1181317]. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (https://proteomecentral.proteomexchange.org) via the iProX partner repository with the dataset identifier PXD057872.
Conflicts of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
This study was funded by the National Natural Science Foundation of China (No. 32360908) for L.K., Jiangxi Provincial Social Science Fund Project [No. 22TQ08D] for Y.G., Natural Science Foundation of Jiangxi Province (20224ACB205004) and the Nanchang City Key Laboratory of Animal Virus and Genetic Engineering [2021-NCZDSYS-008] for L.K.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Adler H., Gould S., Hine P., Snell L.B., Wong W., Houlihan C.F., Osborne J.C., Rampling T., Beadsworth M.B., Duncan C.J., et al. Clinical features and management of human monkeypox: A retrospective observational study in the UK. Lancet Infect. Dis. 2022;22:1153–1162. doi: 10.1016/S1473-3099(22)00228-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gong Q., Wang C., Chuai X., Chiu S. Monkeypox virus: A re-emergent threat to humans. Virol. Sin. 2022;37:477–482. doi: 10.1016/j.virs.2022.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Lum F.M., Torres-Ruesta A., Tay M.Z., Lin R.T.P., Lye D.C., Renia L., Ng L.F.P. Monkeypox: Disease epidemiology, host immunity and clinical interventions. Nat. Rev. Immunol. 2022;22:597–613. doi: 10.1038/s41577-022-00775-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Islam M.A., Mumin J., Haque M.M., Haque M.A., Khan A., Bhattacharya P., Haque M.A. Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions. Infect. Med. 2023;2:262–272. doi: 10.1016/j.imj.2023.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wang Y., Zhang J., Li M., Jia M., Yang L., Wang T., Wang Y., Kang L., Li M., Kong L. Transcriptome and proteomic analysis of mpox virus F3L-expressing cells. Front. Cell. Infect. Microbiol. 2024;14:1354410. doi: 10.3389/fcimb.2024.1354410. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Hatmal M.M., Al-Hatamleh M.A.I., Olaimat A.N., Ahmad S., Hasan H., Ahmad Suhaimi N.A., Albakri K.A., Abedalbaset Alzyoud A., Kadir R., Mohamud R. Comprehensive literature review of monkeypox. Emerg. Microbes Infect. 2022;11:2600–2631. doi: 10.1080/22221751.2022.2132882. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Tiecco G., Degli Antoni M., Storti S., Tomasoni L.R., Castelli F., Quiros-Roldan E. Monkeypox, a Literature Review: What Is New and Where Does This concerning Virus Come From? Viruses. 2022;14:1894. doi: 10.3390/v14091894. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Yu Z., Zou X., Deng Z., Zhao M., Gu C., Fu L., Xiao W., He M., He L., Yang Q., et al. Genome analysis of the mpox (formerly monkeypox) virus and characterization of core/variable regions. Genomics. 2024;116:110763. doi: 10.1016/j.ygeno.2023.110763. [DOI] [PubMed] [Google Scholar]
- 9.Shchelkunov S.N., Totmenin A.V., Safronov P.F., Mikheev M.V., Gutorov V.V., Ryazankina O.I., Petrov N.A., Babkin I.V., Uvarova E.A., Sandakhchiev L.S., et al. Analysis of the monkeypox virus genome. Virology. 2002;297:172–194. doi: 10.1006/viro.2002.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Monzon S., Varona S., Negredo A., Vidal-Freire S., Patino-Galindo J.A., Ferressini-Gerpe N., Zaballos A., Orviz E., Ayerdi O., Munoz-Gomez A., et al. Monkeypox virus genomic accordion strategies. Nat. Commun. 2024;15:3059. doi: 10.1038/s41467-024-46949-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Likos A.M., Sammons S.A., Olson V.A., Frace A.M., Li Y., Olsen-Rasmussen M., Davidson W., Galloway R., Khristova M.L., Reynolds M.G., et al. A tale of two clades: Monkeypox viruses. Pt 10J. Gen. Virol. 2005;86:2661–2672. doi: 10.1099/vir.0.81215-0. [DOI] [PubMed] [Google Scholar]
- 12.Damon I.K. Status of human monkeypox: Clinical disease, epidemiology and research. Vaccine. 2011;29((Suppl. S4)):D54–D59. doi: 10.1016/j.vaccine.2011.04.014. [DOI] [PubMed] [Google Scholar]
- 13.Happi C., Adetifa I., Mbala P., Njouom R., Nakoune E., Happi A., Ndodo N., Ayansola O., Mboowa G., Bedford T., et al. Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus. PLoS Biol. 2022;20:e3001769. doi: 10.1371/journal.pbio.3001769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Faye O., Pratt C.B., Faye M., Fall G., Chitty J.A., Diagne M.M., Wiley M.R., Yinka-Ogunleye A.F., Aruna S., Etebu E.N., et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect. Dis. 2018;18:246. doi: 10.1016/S1473-3099(18)30043-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Antinori A., Mazzotta V., Vita S., Carletti F., Tacconi D., Lapini L.E., D’Abramo A., Cicalini S., Lapa D., Pittalis S., et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Eurosurveillance. 2022;27:2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Vivancos R., Anderson C., Blomquist P., Balasegaram S., Bell A., Bishop L., Brown C.S., Chow Y., Edeghere O., Florence I., et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance. 2022;27:2200422. doi: 10.2807/1560-7917.ES.2022.27.22.2200422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sahu A., Gaur M., Mahanandia N.C., Subudhi E., Swain R.P., Subudhi B.B. Identification of core therapeutic targets for Monkeypox virus and repurposing potential of drugs against them: An in silico approach. Comput. Biol. Med. 2023;161:106971. doi: 10.1016/j.compbiomed.2023.106971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Park C., Walsh D. Ribosomes in poxvirus infection. Curr. Opin. Virol. 2022;56:101256. doi: 10.1016/j.coviro.2022.101256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Seet B.T., Johnston J.B., Brunetti C.R., Barrett J.W., Everett H., Cameron C., Sypula J., Nazarian S.H., Lucas A., McFadden G. Poxviruses and immune evasion. Annu. Rev. Immunol. 2003;21:377–423. doi: 10.1146/annurev.immunol.21.120601.141049. [DOI] [PubMed] [Google Scholar]
- 20.Upton C., Slack S., Hunter A.L., Ehlers A., Roper R.L. Poxvirus orthologous clusters: Toward defining the minimum essential poxvirus genome. J. Virol. 2003;77:7590–7600. doi: 10.1128/JVI.77.13.7590-7600.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Xu Z., Zikos D., Tamosiunaite A., Klopfleisch R., Osterrieder N., Tischer B.K. Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes. J. Virol. 2014;88:8615–8628. doi: 10.1128/JVI.00901-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Williams O., Wolffe E.J., Weisberg A.S., Merchlinsky M. Vaccinia virus WR gene A5L is required for morphogenesis of mature virions. J. Virol. 1999;73:4590–4599. doi: 10.1128/JVI.73.6.4590-4599.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Condit R.C., Moussatche N., Traktman P. In a nutshell: Structure and assembly of the vaccinia virion. Adv. Virus Res. 2006;66:31–124. doi: 10.1016/S0065-3527(06)66002-8. [DOI] [PubMed] [Google Scholar]
- 24.Risco C., Rodriguez J.R., Demkowicz W., Heljasvaara R., Carrascosa J.L., Esteban M., Rodriguez D. The vaccinia virus 39-kDa protein forms a stable complex with the p4a/4a major core protein early in morphogenesis. Virology. 1999;265:375–386. doi: 10.1006/viro.1999.0046. [DOI] [PubMed] [Google Scholar]
- 25.Huang Y., Bergant V., Grass V., Emslander Q., Hamad M.S., Hubel P., Mergner J., Piras A., Krey K., Henrici A., et al. Multi-omics characterization of the monkeypox virus infection. Nat. Commun. 2024;15:6778. doi: 10.1038/s41467-024-51074-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wang Y., Li Y., Li M., Wang K., Xiong J., Wang T., Wang Y., Guo Y., Kong L., Li M. A Combined Transcriptomic and Proteomic Analysis of Monkeypox Virus A23 Protein on HEK293T Cells. Int. J. Mol. Sci. 2024;25:8678. doi: 10.3390/ijms25168678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Brussow H. Pandemic potential of poxviruses: From an ancient killer causing smallpox to the surge of monkeypox. Microb. Biotechnol. 2023;16:1723–1735. doi: 10.1111/1751-7915.14294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Liu J., Corroyer-Dulmont S., Prazak V., Khusainov I., Bahrami K., Welsch S., Vasishtan D., Obarska-Kosinska A., Thorkelsson S.R., Grunewald K., et al. The palisade layer of the poxvirus core is composed of flexible A10 trimers. Nat. Struct. Mol. Biol. 2024;31:1105–1113. doi: 10.1038/s41594-024-01218-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Ren S., Ur Rehman Z., Gao B., Yang Z., Zhou J., Meng C., Song C., Nair V., Sun Y., Ding C. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells. PLoS Pathog. 2020;16:e1008514. doi: 10.1371/journal.ppat.1008514. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Hoang H.D., Neault S., Pelin A., Alain T. Emerging translation strategies during virus-host interaction. Wiley Interdiscip. Rev. RNA. 2021;12:e1619. doi: 10.1002/wrna.1619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Strnadova P., Ren H., Valentine R., Mazzon M., Sweeney T.R., Brierley I., Smith G.L. Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. PLoS Pathog. 2015;11:e1005151. doi: 10.1371/journal.ppat.1005151. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhan Y., Yu S., Yang S., Qiu X., Meng C., Tan L., Song C., Liao Y., Liu W., Sun Y., et al. Newcastle Disease virus infection activates PI3K/Akt/mTOR and p38 MAPK/Mnk1 pathways to benefit viral mRNA translation via interaction of the viral NP protein and host eIF4E. PLoS Pathog. 2020;16:e1008610. doi: 10.1371/journal.ppat.1008610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Thoms M., Buschauer R., Ameismeier M., Koepke L., Denk T., Hirschenberger M., Kratzat H., Hayn M., Mackens-Kiani T., Cheng J., et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science. 2020;369:1249–1255. doi: 10.1126/science.abc8665. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Meade N., DiGiuseppe S., Walsh D. Translational control during poxvirus infection. Wiley Interdiscip. Rev. RNA. 2019;10:e1515. doi: 10.1002/wrna.1515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Park C., Walsh D. RACK1 Regulates Poxvirus Protein Synthesis Independently of Its Role in Ribosome-Based Stress Signaling. J. Virol. 2022;96:e0109322. doi: 10.1128/jvi.01093-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Stern-Ginossar N., Thompson S.R., Mathews M.B., Mohr I. Translational Control in Virus-Infected Cells. Cold Spring Harb. Perspect. Biol. 2019;11:a033001. doi: 10.1101/cshperspect.a033001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Brugier A., Hafirrassou M.L., Pourcelot M., Baldaccini M., Kril V., Couture L., Kummerer B.M., Gallois-Montbrun S., Bonnet-Madin L., Vidalain P.O., et al. RACK1 Associates with RNA-Binding Proteins Vigilin and SERBP1 to Facilitate Dengue Virus Replication. J. Virol. 2022;96:e0196221. doi: 10.1128/jvi.01962-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cui N., Han X., Yang X., Zhao X., Huang Q., Xu C., Su S. Avian leukosis virus usurps the cellular SERBP1 protein to enhance its transcription and promote productive infections in avian cells. Poult. Sci. 2024;103:103755. doi: 10.1016/j.psj.2024.103755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Jha S., Rollins M.G., Fuchs G., Procter D.J., Hall E.A., Cozzolino K., Sarnow P., Savas J.N., Walsh D. Trans-kingdom mimicry underlies ribosome customization by a poxvirus kinase. Nature. 2017;546:651–655. doi: 10.1038/nature22814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kosti A., de Araujo P.R., Li W.Q., Guardia G.D.A., Chiou J., Yi C., Ray D., Meliso F., Li Y.M., Delambre T., et al. The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation. Genome Biol. 2020;21:195. doi: 10.1186/s13059-020-02115-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Muto A., Sugihara Y., Shibakawa M., Oshima K., Matsuda T., Nadano D. The mRNA-binding protein Serbp1 as an auxiliary protein associated with mammalian cytoplasmic ribosomes. Cell Biochem. Funct. 2018;36:312–322. doi: 10.1002/cbf.3350. [DOI] [PubMed] [Google Scholar]
- 42.Ahn J.W., Kim S., Na W., Baek S.J., Kim J.H., Min K., Yeom J., Kwak H., Jeong S., Lee C., et al. SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase. Nucleic Acids Res. 2015;43:6321–6333. doi: 10.1093/nar/gkv592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Brown A., Baird M.R., Yip M.C., Murray J., Shao S. Structures of translationally inactive mammalian ribosomes. eLife. 2018;7:e40486. doi: 10.7554/eLife.40486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Greseth M.D., Traktman P. The Life Cycle of the Vaccinia Virus Genome. Annu. Rev. Virol. 2022;9:239–259. doi: 10.1146/annurev-virology-091919-104752. [DOI] [PubMed] [Google Scholar]
- 45.Coulibaly F. Structure of the poxvirus core. Nat. Struct. Mol. Biol. 2024;31:1001–1003. doi: 10.1038/s41594-024-01331-5. [DOI] [PubMed] [Google Scholar]
- 46.Moss B. Poxvirus membrane biogenesis. Virology. 2015;479–480:619–626. doi: 10.1016/j.virol.2015.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Hollinshead M., Rodger G., Van Eijl H., Law M., Hollinshead R., Vaux D.J., Smith G.L. Vaccinia virus utilizes microtubules for movement to the cell surface. J. Cell Biol. 2001;154:389–402. doi: 10.1083/jcb.200104124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Cudmore S., Blasco R., Vincentelli R., Esteban M., Sodeik B., Griffiths G., Krijnse Locker J. A vaccinia virus core protein, p39, is membrane associated. J. Virol. 1996;70:6909–6921. doi: 10.1128/jvi.70.10.6909-6921.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Letafati A., Sakhavarz T. Monkeypox virus: A review. Microb. Pathog. 2023;176:106027. doi: 10.1016/j.micpath.2023.106027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Xue B., Hou G., Zhang G., Huang J., Li L., Nan Y., Mu Y., Wang L., Zhang L., Han X., et al. MYH9 Aggregation Induced by Direct Interaction With PRRSV GP5 Ectodomain Facilitates Viral Internalization by Permissive Cells. Front. Microbiol. 2019;10:2313. doi: 10.3389/fmicb.2019.02313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Arii J., Goto H., Suenaga T., Oyama M., Kozuka-Hata H., Imai T., Minowa A., Akashi H., Arase H., Kawaoka Y., et al. Non-muscle myosin IIA is a functional entry receptor for herpes simplex virus-1. Nature. 2010;467:859–862. doi: 10.1038/nature09420. [DOI] [PubMed] [Google Scholar]
- 52.Liu Q., Cheng C., Huang J., Yan W., Wen Y., Liu Z., Zhou B., Guo S., Fang W. MYH9: A key protein involved in tumor progression and virus-related diseases. Biomed. Pharmacother. 2024;171:116118. doi: 10.1016/j.biopha.2023.116118. [DOI] [PubMed] [Google Scholar]
- 53.Liang J., Ruthel G., Freedman B.D., Harty R.N. WWOX-Mediated Degradation of AMOTp130 Negatively Affects Egress of Filovirus VP40 Virus-Like Particles. J. Virol. 2022;96:e0202621. doi: 10.1128/jvi.02026-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Mercenne G., Alam S.L., Arii J., Lalonde M.S., Sundquist W.I. Angiomotin functions in HIV-1 assembly and budding. eLife. 2015;4:e03778. doi: 10.7554/eLife.03778. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The original contributions presented in the study are publicly available. This RNA-seq data can be found here: [NCBI/PRJNA1181317]. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (https://proteomecentral.proteomexchange.org) via the iProX partner repository with the dataset identifier PXD057872.






